E.E. Geduld’s Novavax NVAX Stock Holding History

E.E. Geduld’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,500	Closed	-$104K	–	198
2016 Q3	$104K	Buy	+2,500	New	+$323K	0.1%	129
2015 Q4	–	Sell	-1,125	Closed	-$159K	–	209
2015 Q3	$159K	Buy	1,125 +125	+13%	+$28K	0.15%	112
2015 Q2	$223K	Sell	1,000 -786	-44%	-$138K	0.14%	163
2015 Q1	$295K	Sell	1,786 -724	-29%	-$118K	0.2%	121
2014 Q4	$298K	Buy	2,510 +500	+25%	+$52.3K	0.16%	104
2014 Q3	$168K	Sell	2,010 -150	-7%	-$13.6K	0.12%	152
2014 Q2	$200K	Sell	2,160 -2,090	-49%	-$184K	0.12%	186
2014 Q1	$385K	Sell	4,250 -750	-15%	-$83.8K	0.21%	125
2013 Q4	$512K	Buy	+5,000	New	+$353K	0.25%	87

Other funds holding NVAX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

QIM

Quantitative Investment Management Charlottesville, Virginia $917M AUM 3.96% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

E.E. Geduld's NVAX Position: Q4 2016 in Review

E.E. Geduld sold out of Novavax (NVAX) in Q4 2016, closing a stake of 2,500 shares — an estimated $104K sold.

E.E. Geduld first reported a position in NVAX in Q4 2013 and held it in 9 quarters. The position peaked at $512K in Q4 2013. 143 funds tracked by Wall St. Rank hold NVAX as of Q4 2016.

E.E. Geduld reported no remaining Novavax position as of Q4 2016 after selling out during the quarter.
E.E. Geduld sold 2,500 Novavax shares in Q4 2016, an estimated $104K.
E.E. Geduld first reported a position in Novavax in Q4 2013 and held it in 9 quarters.
E.E. Geduld's Novavax position peaked at $512K in Q4 2013.
143 funds tracked by Wall St. Rank held Novavax as of Q4 2016.

Based on E.E. Geduld's 13F filing for Q4 2016, filed 8 Feb 2017.